Quidel | QDEL - Equity Capital And Reserves


Quidel reported $2.04B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Agilent USD 6.74B 371M Sep/2025
Avanos Medical USD 778M 1.7M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.41B 52.13M Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Exact Sciences USD 2.5B 32M Sep/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Merit Medical Systems USD 1.53B 41.36M Sep/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
Neogen USD 2.1B 14.16M Sep/2025
Quidel USD 2.04B 756.3M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
STAAR Surgical USD 353.78M 17.21M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.33B 170.88M Sep/2025